RAPID FIRE CGM INTERPRETATION FOR EFFICIENT AND EFFECTIVE PATIENT CARE
An Enduring CME Activity – 1.0 CEUs
There is little understanding amongst HCPs about the tremendous benefits of CGM and how a patient could have greater control of their diabetes, while still having a good quality of life in terms of dietary freedom and exercise. This program will educate HCPs about these advances in technology, how to use them and how to translate this clinically valuable information to their patients. They will also review a systematic approach to reading CGM downloads to quickly identify problem areas to focus clinical visits on and learn practical tools for how to formulate a clinical plan for the patient moving forward.
Go to video and begin CME activity HERE | Please see the full accreditation information HERE
*To receive credit you must complete/pass the post-test and submit a program evaluation. Your certificate will auto-generate for download.*
PROGRAM OVERVIEW
• Overview and introduction to Continuous Glucose Monitoring (CGM)
• Benefits of the Metrics that come from the CGM Downloads
• How to read a CGM download
• Case presentations
LEARNING OBJECTIVES
After completing this activity, learners should:
- Describe what are the features of CGM including the metrics it provides.
- Review a standardized approach to reading CGM downloads in an efficient and effective manner.
- Be able to identify the main clinical abnormalities(s) quickly in any patient download to focus the clinic visit.
- Be able to teach patients about alert setting and how to respond to the trend arrows.
- Explain how to formulate a clinical plan once reviewing the patient characteristics and CGM download and other important laboratory data.
WHO CAN BENEFIT MOST
This course is designed for diabetes healthcare providers including endocrinologists, primary care physicians, nurse practitioners, physician assistants, nurses, certified diabetes educators, pharmacists, and other healthcare providers wanting to expand their knowledge of diabetes management using CGM technology.
IN-DEPTH PROGRAM TOPICS
1. CGM Technology Overview
Latest advancements in CGM devices, comparison of different CGM systems available in the market, and understanding CGM accuracy and limitations.
2. CGM Metrics and Their Clinical Significance
Time in Range (TIR) and its correlation with long-term outcomes, Glucose Management Indicator (GMI) vs. HbA1c, and Coefficient of Variation (CV) and its importance in assessing glycemic variability.
3. Systematic Approach to CGM Data Interpretation
Step-by-step guide to analyzing CGM reports, identifying patterns and trends in glucose data, and prioritizing areas for intervention based on CGM insights.
4. Case Studies in CGM Interpretation
Real-world examples of CGM data from diverse patient populations, interactive sessions on rapid CGM data analysis, and developing personalized treatment plans based on CGM insights.
5. Patient Education Strategies
Teaching patients to use CGM data for self-management effectively, strategies for setting and adjusting CGM alerts and alarms, and empowering patients to make data-driven decisions in their diabetes care.
Successful Completion
To receive a Statement of Credit you must view the entire 60 min enduring activity. Your Statement of Credit will be issued electronically immediately upon submission of the evaluation form to the email address provided. Contact Olivia Montanari at olivia@tcoyd.org with questions.
Program Fees and Registration
This is a complimentary program. Registration is not required to view the materials, however, to obtain credit learners will be required to submit necessary identifying information, complete a post-test, and evaluation.
Acknowledgement of Joint Providership
This activity is jointly provided by The Association of Diabetes Care & Education Specialists (ADCES) and TCOYD. The Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. ADCES’ Joint Accreditation Status also includes the Commission on Dietetic Registration (CDR) and American Academy of Physician Assistants (AAPA). ADCES will provide accreditation for this activity to ensure the content is scientifically based, accurate, current, and objective. Any conflicts among faculty or others involved in the planning and execution of this activity will be resolved.
This activity is provided as enduring material via tcoyd.org and will be available from 1/31/24 to 1/31/27.
SPEAKERS & FACULTY
*extra-relatable faculty (they're living with type 1)
*STEVEN V. EDELMAN, MD
Founder & Director, TCOYD; Endocrinologist, Clinical Professor of Medicine, University of California, San Diego (UCSD) School of Medicine; Director, Diabetes Care Clinic, VA Medical Center San Diego
Dr. Edelman is a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California, San Diego (UCSD) and the Veterans Affairs (VA) Healthcare System of San Diego. Dr. Edelman, who has type 1 diabetes himself, has written more than 200 articles, five books, and has won numerous awards for teaching and humanitarianism. He has been chosen by the medical students at UCSD as the ‘teacher of the year’ numerous times. Among his many honors, Dr. Edelman has received the ‘Diabetes Educator Of The Year’ award by the American Diabetes Association, the ‘Distinction in Endocrinology’ award by the American Association of Clinical Endocrinologists, and named ‘Top 1% of U.S. Endocrinologists’ by US News and World Report.
*JEREMY PETTUS, MD
Type 1 Track & Professional Education Director, Endocrinologist, Associate Professor of Medicine, UCSD School of Medicine
Dr. Jeremy Pettus was diagnosed with type 1 diabetes when he was 15 years old. Since that time he has dedicated his career to educating and treating others like himself. He is currently an Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego. There, he focuses primarily on clinical trials to develop and test new and innovative therapies for people living with diabetes. These include studies ranging from medications to reverse or slow the disease once it occurs, to islet cell transplantation strategies, to device studies such as artificial pancreas technology. As somebody who has the disease himself, sees patients with type 1, and is actively working on curing/treating the disease, we are honored to have him at TCOYD.
– Acknowledgement of Financial Support –
This activity is supported by educational grants from Abbott Diabetes Care, Ascensia Diabetes Care and Dexcom, Inc.
In support of improving patient care, this activity has been planned by Taking Control of Your Diabetes and the Association of Diabetes Care & Education Specialists. Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Accreditation Council for Pharmacy Education
The Universal Activity Number is JA4008258-9999-24-029-H01-P; JA4008258-9999-24-029-H01-T. This Knowledge-based activity has been approved for 1.0 contact hour(s). This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.
American Medical Association (AMA)
Association of Diabetes Care & Education Specialists designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Association of Diabetes Care & Education Specialists designates this activity for a maximum of 1.0 ANCC contact hours. This activity discusses 0.0 contact hours of pharmacotherapeutic content.
The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 1.0 contact hours.
The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Commission on Dietetic Registration (CDR): CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activity. Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.
Certified Diabetes Care and Education Specialists: To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.
Other Health Professionals
It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.
Speaker Disclosures
In accordance with the ACCME Standards for Integrity and Independence, the Association of Diabetes Care & Education Specialists (ADCES) requires anyone in a position to affect or control continuing education content (e.g., authors, presenters, and program planners) to disclose all financial relationships with ineligible companies. It is the responsibility of ADCES to mitigate and disclose all relevant conflicts of interest. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of the presentation.
Relevant disclosures (or lack thereof) among education activity planners and faculty are as follows:
Speakers:
Steven V. Edelman, MD
Board of Directors: Senseonics, Team Type 1 501(c)(3), TCOYD 501(c)(3)
Advisor/Consultant/Speaker: Eli Lilly, NovoNordisk, Vertex Pharmaceuticals, Sanofi, Xeris Pharmaceuticals
Shareholder: Senseonics
Jeremy H. Pettus, MD
Consultant: Carmot Therapeutics, NovoNordisk, Sanofi
Speakers Bureau: MannKind Corporation, Sanofi
All relevant relationships have been mitigated.
Planners:
Olivia Montanari – No financial relationships to report
Autumn Zarlengo – No Financial Relationships to report
